FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing bosutinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bosutinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dacomitinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacomitinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing larotrectinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Larotrectinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing larotrectinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only larotrectinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lenvatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only lenvatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenvatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lenvatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lorlatinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lorlatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lorlatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only lorlatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing imatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing imatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only imatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely imatinib mesilate 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Idelalisib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing idelalisib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gilteritinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gilteritinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing gilteritinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only gilteritinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lapatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only lapatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lapatinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing lapatinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cobimetinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing cobimetinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only cobimetinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cobimetinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dinutuximab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only dinutuximab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dinutuximab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing dinutuximab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Crisantaspase Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing crisantaspase in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only crisantaspase in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing crisantaspase (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bicalutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bicalutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bicalutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bicalutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only 5-aminolevulinic acid in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methyl aminolevulinate hydrochloride 168 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aminolevulinic acid hydrochloride 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 milligram/1 gram conventional release cutaneous cream Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing 5-aminolevulinic acid Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only 5-aminolevulinic acid (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing aminoglutethimide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only aminoglutethimide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aminoglutethimide 250 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing aminoglutethimide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aminoglutethimide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing aldesleukin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aldesleukin 22 million unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing aldesleukin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only aldesleukin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Aldesleukin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing 3'-deoxyadenosine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only 3'-deoxyadenosine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing anastrozole Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing anastrozole in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only anastrozole in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely anastrozole 1 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Anastrozole Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tositumomab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tositumomab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Medicinal product containing triazene and acting as antineoplastic agent (product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trifluridine + Tipiracil Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tipiracil and trifluridine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tipiracil and trifluridine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tipiracil and trifluridine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing flutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only flutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Flutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flutamide 250 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flutamide 125 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing flutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only forodesine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing forodesine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Triptorelin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only triptorelin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing triptorelin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 12 of 26 Next End

This concept is not in any reference sets

Back to Start